Skip to main content
Clinical Trials/ITMCTR2000003225
ITMCTR2000003225Recruiting未知

Clinical study for Danggui Shaoyao Powder in the treatment of novel coronavirus pneumonia (COVID-19)

nion Hospital of Tongji Medical College, Huazhong University of Science and Technology0 sitesStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. novel coronavirus pneumonia diagnostic criteria;
  • 2. age unlimited, male and female unlimited.

Exclusion Criteria

  • 1. not qualified for novel coronavirus pneumonia diagnostic criteria;
  • 2. Pregnant or lactating women who are allergic to the drug;
  • 3. There are factors influencing the observation of curative effect;
  • 4. Those who do not meet the inclusion criteria, fail to use the medicine according to the regulations, fail to determine the curative effect or incomplete data, which affect the judgment of curative effect or safety.

Investigators

Sponsor
nion Hospital of Tongji Medical College, Huazhong University of Science and Technology

Similar Trials

Danggui Shaoyao Powder in the synergistic... | Clinical Trial